Seaman Scott B
Insider CIK 1359850 · OPXA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-09-30 | 2016-10-04 | 6,455 | — | $0 | 29,989 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-06-30 | 2016-07-01 | 6,455 | — | $0 | 23,534 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-05-16 | 2016-05-18 | 6,455 | — | $0 | 17,079 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 44,087 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 44,087 | — | $0 | 44,087 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 518,707 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 518,707 | — | $0 | 518,707 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise | 2015-04-08 | 2015-04-09 | 518,707 | — | $0 | 1,037,414 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise | 2015-04-08 | 2015-04-09 | 44,087 | — | $0 | 85,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 35,706 | — | $0 | 35,706 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 23,804 | — | $0 | 23,804 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 71,410 | — | $0 | 71,410 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 5,896 | — | $0 | 5,896 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 8,844 | — | $0 | 8,844 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 17,686 | — | $0 | 17,686 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | P Buy | 2013-12-18 | 2013-12-18 | 30,000 | $1.70 | $51.0K | 40,913 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | C Conversion deriv | 2013-09-24 | 2013-09-26 | 0 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | C Conversion | 2013-09-24 | 2013-09-26 | 269,182 | $1.91 | $514.1K | 518,708 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2013-06-30 | 2013-07-02 | 19,345 | $1.54 | $29.8K | 249,526 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 17,143 | — | $0 | 17,143 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | S Sale deriv | 2013-02-19 | 2013-02-19 | 1,318 | $0.01 | $13 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | S Sale deriv | 2013-02-14 | 2013-02-19 | 11,966 | $0.01 | $120 | 1,318 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | S Sale deriv | 2013-02-13 | 2013-02-19 | 36,691 | $0.01 | $367 | 13,284 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | S Sale deriv | 2013-02-12 | 2013-02-19 | 25 | $0.02 | $1 | 49,975 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-01-29 | 2013-01-31 | 22,950 | — | $0 | 22,950 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2012-12-31 | 2013-01-24 | 19,978 | $1.33 | $26.6K | 230,181 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-07-25 | 2012-07-27 | 0 | — | $0 | 468,750 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-07-25 | 2012-07-27 | 468,750 | — | $0 | 5,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 20,600 | — | $0 | 20,600 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 10,000 | — | $0 | 10,000 | SEC↗ |